In order to verify the therapeutic effect of stem cells on type 2 diabetes, Bhansali [21] injected hMSCs in patients with type 2 diabetes through pancreatic artery puncture and found that the demand for insulin was significantly reduced after hMSCs injection. The gene discussed is INS; the disease is type 2 diabetes mellitus.